Abeona Therapeutics (ABEO) Operating Expenses (2016 - 2025)
Historic Operating Expenses for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to $24.0 million.
- Abeona Therapeutics' Operating Expenses rose 5652.0% to $24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $83.6 million, marking a year-over-year increase of 3763.25%. This contributed to the annual value of $64.2 million for FY2024, which is 2681.15% up from last year.
- Per Abeona Therapeutics' latest filing, its Operating Expenses stood at $24.0 million for Q3 2025, which was up 5652.0% from $23.2 million recorded in Q2 2025.
- Over the past 5 years, Abeona Therapeutics' Operating Expenses peaked at $49.7 million during Q4 2021, and registered a low of $9.0 million during Q2 2022.
- Moreover, its 5-year median value for Operating Expenses was $14.6 million (2021), whereas its average is $17.2 million.
- As far as peak fluctuations go, Abeona Therapeutics' Operating Expenses soared by 18405.03% in 2021, and later plummeted by 7380.97% in 2022.
- Abeona Therapeutics' Operating Expenses (Quarter) stood at $49.7 million in 2021, then tumbled by 73.81% to $13.0 million in 2022, then rose by 1.58% to $13.2 million in 2023, then rose by 26.22% to $16.7 million in 2024, then surged by 44.06% to $24.0 million in 2025.
- Its Operating Expenses stands at $24.0 million for Q3 2025, versus $23.2 million for Q2 2025 and $19.7 million for Q1 2025.